曲美他嗪对糖尿病合并冠心病患者的疗效：一项随机对照试验的荟萃分析

林烨; 王祯莲; 严敏; 朱飞雨; 端烨; 孙志琴

doi:10.24920/003678

Your Location：

Home >

Browse articles >

曲美他嗪对糖尿病合并冠心病患者的疗效：一项随机对照试验的荟萃分析

中国医学科学杂志（英文版） 2020年35卷第3期页码：226-238

Original Article | Updated：2024-04-10

- 曲美他嗪对糖尿病合并冠心病患者的疗效：一项随机对照试验的荟萃分析
- Affiliations：
  
  1. 1School of Pharmacy, Changzhou University, Changzhou 213164, China
  2. 2Changzhou No. 2 People's Hospital, Changzhou 213164, China
- Author bio：
  
  * E-mail: sun_zhiqin@163.com
- Funds：
- DOI：10.24920/003678
  中图分类号：
- 收稿日期：2020-01-13，
  
  网络出版日期：2020-09-30，
  
  纸质出版日期：2020-09-30
- Accepted：
Scan QR Code
林烨, 王祯莲, 严敏, 等. 曲美他嗪对糖尿病合并冠心病患者的疗效：一项随机对照试验的荟萃分析[J]. 中国医学科学杂志（英文版）, 2020,35(3):226-238.

Lin Ye, Wang Zhenlian, Yan Min, et al. Effect of Trimetazidine on Diabetic Patients with Coronary Heart Diseases: A Meta-Analysis of Randomized, Controlled Trials[J]. Chinese medical sciences journal, 2020, 35(3): 226-238.
林烨, 王祯莲, 严敏, 等. 曲美他嗪对糖尿病合并冠心病患者的疗效：一项随机对照试验的荟萃分析[J]. 中国医学科学杂志（英文版）, 2020,35(3):226-238. DOI： 10.24920/003678.

Lin Ye, Wang Zhenlian, Yan Min, et al. Effect of Trimetazidine on Diabetic Patients with Coronary Heart Diseases: A Meta-Analysis of Randomized, Controlled Trials[J]. Chinese medical sciences journal, 2020, 35(3): 226-238. DOI： 10.24920/003678.

摘要

目的

探讨曲美他嗪对糖尿病合并冠心病患者的治疗作用。

方法

我们检索PubMed

EMBASE和Cochrane数据库中2019年5月之前收录的所有关于曲美他嗪对糖尿病合并冠心病患者疗效的随机对照研究。采用Cochrane Collaboration推荐的偏倚风险评估方法评估文献质量。采用用随机或固定模型获得左心室功能、血清葡萄糖代谢、血清脂代谢、心肌缺血发作和运动耐量的合并平均差异

效应大小由95％置信区间（CI）表示。

结果

曲美他嗪辅助治疗有助于改善患者的左心室射血分数（

WMD

=4.39

95％

：3.83

4.95

0.00001）

左心室舒张末期直径（

WMD

=-3.17

95％

：-4.90

-1.44

=0.0003）和左心室收缩末期直径（

WMD

=-4.69

95％

：-8.66

-0.72

=0.02）。曲美他嗪还能降低空腹血糖（

SMD

=-0.43

95％

：-0.70

-0.17

=0.001）、糖基化血红蛋白水平（

WMD

=-0.59

95％

：-0.95

-0.24

=0.001）

血清总胆固醇水平（

WMD

=-20.36

95％

：-39.80

-0.92

=0.04）、低密度脂蛋白胆固醇水平（

WMD

=-20.12

95％

：-32.95

-7.30

=0.002）

心肌缺血发作的发生率（

SMD

=-0.84

95％

：-1.50

-0.18

=0.01）。然而

曲美他嗪不能显著降低血清甘油三酯及高密度脂蛋白胆固醇水平

改善运动耐量。

结论

曲美他嗪辅助治疗能有效改善糖尿病合并冠心病患者的心功能、血糖、血脂代谢及临床症状。

Abstract

Objective

To explore the therapeutic effects of trimetazidine (TMZ) on diabetic patients with coronary heart diseases.

Methods

We conducted a comprehensive electronic search of PubMed

EMBASE

and Cochrane databases between the inception dates of databases and May 2019 (last search conducted on 30 May 2019) to identify randomized controlled trials. The evaluation method recommended by Cochrane Collaboration for bias risk assessment was employed for quality assessment. Random or fixed models were used to investigate pooled mean differences in left ventricular function

serum glucose metabolism

serum lipid profile

myocardial ischemia episodes and exercise tolerance with effect size indicated by the 95% confidence interval (

Results

Additional TMZ treatment contributed to considerable improvement of left ventricular ejection fraction (

WMD

=4.39

95%

: 3.83

4.95

0.00001)

left ventricular end diastolic diameter (

WMD

=-3.17

95%

: -4.90

-1.44

=0.0003) and left ventricular end systolic diameter (

WMD

=-4.69

95%

: -8.66

-0.72

=0.02). TMZ administration also significantly decreased fasting blood glucose (

SMD

=-0.43

95%

: -0.70

-0.17

=0.001)

glycosylated hemoglobin level (

WMD

=-0.59

95%

: -0.95

-0.24

=0.001)

serum level of total cholesterol (

WMD

=-20.36

95%

: -39.80

-0.92

=0.04)

low-density lipoprotein cholesterol (

WMD

=-20.12

95%

: -32.95

-7.30

=0.002) and incidence of myocardial ischemia episodes (

SMD

=-0.84

95%

: -1.50

-0.18

=0.01). However

there were no significant differences in serum triglyceride level

high-density lipoprotein cholesterol

exercise tolerance between the TMZ group and the control group.

Conclusion

TMZ treatment in diabetic patients with coronary heart disease is effective to improve cardiac function

serum glucose and lipid metabolism and clinical symptoms.

关键词

Keywords

references

Zimmet P , Alberti KG , Shaw J . Global and societal implications of the diabetes epidemic . Nature 2001 ; 414 ( 6865 ): 782 - 7 . doi: 10.1038/414782a 10.1038/414782a . https://www.ncbi.nlm.nih.gov/pubmed/11742409 https://www.ncbi.nlm.nih.gov/pubmed/11742409

Ogurtsova K , da Rocha Fernandes JD , Huang Y , et al . IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040 . Diabetes Res Clin Pract 2017 ; 128 : 40 - 50 . doi: 10.1016/j.diabres.2017.03.024 10.1016/j.diabres.2017.03.024 . DOI: 10.1016/j.diabres.2017.03.024 http://doi.org/10.1016/j.diabres.2017.03.024 https://www.ncbi.nlm.nih.gov/pubmed/28437734 https://www.ncbi.nlm.nih.gov/pubmed/28437734

Haffner SM , Lehto S , Ronnemaa T , et al . Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction . NEJM 1998 ; 339 ( 4 ): 229 - 34 . doi: 10.1056/NEJM199807233390404 10.1056/NEJM199807233390404 . DOI: 10.1056/NEJM199807233390404 http://doi.org/10.1056/NEJM199807233390404 https://www.ncbi.nlm.nih.gov/pubmed/9673301 https://www.ncbi.nlm.nih.gov/pubmed/9673301

Aune D , Schlesinger S , Norat T , et al . Diabetes mellitus and the risk of sudden cardiac death: a systematic review and meta-analysis of prospective studies . Nutr Metab Cardiovasc Dis 2018 ; 28 ( 6 ): 543 - 56 . doi: 10.1016/j.numecd.2018.02.011 10.1016/j.numecd.2018.02.011 . DOI: 10.1016/j.numecd.2018.02.011 http://doi.org/10.1016/j.numecd.2018.02.011 https://www.ncbi.nlm.nih.gov/pubmed/29730085 https://www.ncbi.nlm.nih.gov/pubmed/29730085

Esper RJ , Vilarino JO , Machado RA , et al . Endothelial dysfunction in normal and abnormal glucose metabolism . Adv Cardiol 2008 ; 45 : 17 - 43 . doi: 10.1159/000115120 10.1159/000115120 . DOI: 10.1159/000115120 http://doi.org/10.1159/000115120 https://www.ncbi.nlm.nih.gov/pubmed/18230954 https://www.ncbi.nlm.nih.gov/pubmed/18230954

Kawano H , Motoyama T , Hirashima O , et al . Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery . J Am Coll Cardiol 1999 ; 34 ( 1 ): 146 - 54 . doi: 10.1016/s0735-1097(99)00168-0 10.1016/s0735-1097(99)00168-0 . https://www.ncbi.nlm.nih.gov/pubmed/10400004 https://www.ncbi.nlm.nih.gov/pubmed/10400004

Yoshida N , Okumura K , Aso Y . High serum pentosidine concentrations are associated with increased arterial stiffness and thickness in patients with type 2 diabetes . Metabolism 2005 ; 54 ( 3 ): 345 - 50 . doi: 10.1016/j.metabol.2004.09.014 10.1016/j.metabol.2004.09.014 . DOI: 10.1016/j.metabol.2004.09.014 http://doi.org/10.1016/j.metabol.2004.09.014 https://www.ncbi.nlm.nih.gov/pubmed/15736112 https://www.ncbi.nlm.nih.gov/pubmed/15736112

Li L , Pan Y , Dai L , et al . Association of genetic polymorphisms on vascular endothelial growth factor and its receptor genes with susceptibility to coronary heart disease . Med Sci Monit 2016 ; 22 : 31 - 40 . doi: 10.12659/msm.895163 10.12659/msm.895163 . https://www.ncbi.nlm.nih.gov/pubmed/26726843 https://www.ncbi.nlm.nih.gov/pubmed/26726843

Bravo PE , Psaty BM , Di Carli MF , et al . Identification of coronary heart disease in asymptomatic individuals with diabetes mellitus: to screen or not to screen . Colomb Med (Cali) 2015 ; 46 ( 1 ): 41 - 6 .

Chiha M , Njeim M , Chedrawy EG . Diabetes and coronary heart disease: a risk factor for the global epidemic . Int J Hypertens 2012 ; 2012 : 697240 . doi: 10.1155/2012/697240 10.1155/2012/697240 . DOI: 10.1155/2012/697240 http://doi.org/10.1155/2012/697240 https://www.ncbi.nlm.nih.gov/pubmed/23119148 https://www.ncbi.nlm.nih.gov/pubmed/23119148

Roger VL , Go AS , Lloyd-Jones DM , et al . Heart disease and stroke statistics—2011 update: a report from the American Heart Association . Circulation 2011 ; 123 ( 4 ): e18 - e209 . doi: 10.1161/CIR.0b013e3182009701 10.1161/CIR.0b013e3182009701 . https://www.ncbi.nlm.nih.gov/pubmed/21160056 https://www.ncbi.nlm.nih.gov/pubmed/21160056

Donahoe SM , Stewart GC , McCabe CH , et al . Diabetes and mortality following acute coronary syndromes . JAMA 2007 ; 298 ( 7 ): 765 - 75 . doi: 10.1001/jama.298.7.765 10.1001/jama.298.7.765 . https://www.ncbi.nlm.nih.gov/pubmed/17699010 https://www.ncbi.nlm.nih.gov/pubmed/17699010

Ussher JR , Lopaschuk GD . Targeting malonyl CoA inhibition of mitochondrial fatty acid uptake as an approach to treat cardiac ischemia/reperfusion . Basic Res Cardiol 2009 ; 104 ( 2 ): 203 - 10 . doi: 10.1007/s00395-009-0003-9 10.1007/s00395-009-0003-9 . https://www.ncbi.nlm.nih.gov/pubmed/19242641 https://www.ncbi.nlm.nih.gov/pubmed/19242641

Monti LD , Setola E , Fragasso G , et al . Metabolic and endothelial effects of trimetazidine on forearm skeletal muscle in patients with type 2 diabetes and ischemic cardiomyopathy . Am J Physiol 2006 ; 290 ( 1 ): E54 - E9 . doi: 10.1152/ajpendo.00083.2005 10.1152/ajpendo.00083.2005 .

Kantor PF , Lucien A , Kozak R , et al . The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase . Circ Res 2000 ; 86 ( 5 ): 580 - 8 . doi: 10.1161/01.res.86.5.580 10.1161/01.res.86.5.580 . https://www.ncbi.nlm.nih.gov/pubmed/10720420 https://www.ncbi.nlm.nih.gov/pubmed/10720420

Onay-Besikci A , Ozkan SA . Trimetazidine revisited: a comprehensive review of the pharmacological effects and analytical techniques for the determination of trimetazidine . Cardiovas Ther 2008 ; 26 ( 2 ): 147 - 65 . doi: 10.1111/j.1527-3466.2008.00043.x 10.1111/j.1527-3466.2008.00043.x . DOI: 10.1111/j.1527-3466.2008.00043.x http://doi.org/10.1111/j.1527-3466.2008.00043.x http://doi.wiley.com/10.1111/j.1527-3466.2008.00043.x http://doi.wiley.com/10.1111/j.1527-3466.2008.00043.x

Chrusciel P , Rysz J , Banach M . Defining the role of trimetazidine in the treatment of cardiovascular disorders: some insights on its role in heart failure and peripheral artery disease . Drugs 2014 ; 74 ( 9 ): 971 - 80 . doi: 10.1007/s40265-014-0233-5 10.1007/s40265-014-0233-5 . DOI: 10.1007/s40265-014-0233-5 http://doi.org/10.1007/s40265-014-0233-5 http://dx.doi.org/10.1007/s40265-014-0233-5 http://dx.doi.org/10.1007/s40265-014-0233-5

Tsioufis K , Andrikopoulos G , Manolis A . Trimetazidine and cardioprotection: facts and perspectives . Angiology 2015 ; 66 ( 3 ): 204 - 10 . doi: 10.1177/0003319714530040 10.1177/0003319714530040 . https://www.ncbi.nlm.nih.gov/pubmed/24719262 https://www.ncbi.nlm.nih.gov/pubmed/24719262

Li R , Tang X , Jing Q , et al . The effect of trimetazidine treatment in patients with type 2 diabetes undergoing percutaneous coronary intervention for AMI . Am J Emerg Med 2017 ; 35 ( 11 ): 1657 - 61 . doi: 10.1016/j.ajem.2017.05.024 10.1016/j.ajem.2017.05.024 . DOI: 10.1016/j.ajem.2017.05.024 http://doi.org/10.1016/j.ajem.2017.05.024 https://www.ncbi.nlm.nih.gov/pubmed/28587952 https://www.ncbi.nlm.nih.gov/pubmed/28587952

Xu X , Zhang W , Zhou Y , et al . Effect of trimetazidine on recurrent angina pectoris and left ventricular structure in elderly multivessel coronary heart disease patients with diabetes mellitus after drug-eluting stent implantation: a single-centre, prospective, randomized, double-blind study at 2-year follow-up . Clin Drug Investig 2014 ; 34 ( 4 ): 251 - 8 . doi: 10.1007/s40261-014-0170-9 10.1007/s40261-014-0170-9 . https://www.ncbi.nlm.nih.gov/pubmed/24470342 https://www.ncbi.nlm.nih.gov/pubmed/24470342

Shehata M . Cardioprotective effects of oral trimetazidine in diabetic patients with anterior wall myocardial infarction treated with thrombolysis . Cardiol Res 2014 ; 5 ( 2 ): 58 - 67 . doi: 10.14740/cr330w 10.14740/cr330w . DOI: 10.14740/cr330w http://doi.org/10.14740/cr330w https://www.ncbi.nlm.nih.gov/pubmed/28392876 https://www.ncbi.nlm.nih.gov/pubmed/28392876

Belardinelli R , Cianci G , Gigli M , et al . Effects of trimetazidine on myocardial perfusion and left ventricular systolic function in type 2 diabetic patients with ischemic cardiomyopathy . J Cardiovas Pharmacol 2008 ; 51 ( 6 ): 611 - 5 . doi: 10.1097/FJC.0b013e31817bdd66 10.1097/FJC.0b013e31817bdd66 . DOI: 10.1097/FJC.0b013e31817bdd66 http://doi.org/10.1097/FJC.0b013e31817bdd66 http://journals.lww.com/00005344-200806000-00013 http://journals.lww.com/00005344-200806000-00013

Ribeiro LW , Ribeiro JP , Stein R , et al . Trimetazidine added to combined hemodynamic antianginal therapy in patients with type 2 diabetes: a randomized crossover trial . Am Heart J 2007 ; 154 ( 1 ): 78.e1 - 7 . doi: 10.1016/j.ahj.2007.04.026 10.1016/j.ahj.2007.04.026 . DOI: 10.1016/j.ahj.2007.04.026 http://doi.org/10.1016/j.ahj.2007.04.026 https://linkinghub.elsevier.com/retrieve/pii/S000287030700347X https://linkinghub.elsevier.com/retrieve/pii/S000287030700347X

Marazzi G , Wajngarten M , Vitale C , et al . Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease . Int J Cardiol 2007 ; 120 ( 1 ): 79 - 84 . doi: 10.1016/j.ijcard.2006.08.082 10.1016/j.ijcard.2006.08.082 . DOI: 10.1016/j.ijcard.2006.08.082 http://doi.org/10.1016/j.ijcard.2006.08.082 https://www.ncbi.nlm.nih.gov/pubmed/17134770 https://www.ncbi.nlm.nih.gov/pubmed/17134770

Rosano GMC , Vitale C , Sposato B , et al . Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: A double-blind placebo-controlled study . Cardiovas Diabetol 2003 ; 2 : 16 . doi: 10.1186/1475-2840-2-16 10.1186/1475-2840-2-16 . DOI: 10.1186/1475-2840-2-16 http://doi.org/10.1186/1475-2840-2-16 http://cardiab.biomedcentral.com/articles/10.1186/1475-2840-2-16 http://cardiab.biomedcentral.com/articles/10.1186/1475-2840-2-16

Fragasso G , Piatti Md PM , Monti L , et al . Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy . Am Heart J 2003 ; 146 ( 5 ): E18 . doi: 10.1016/S0002-8703(03)00415-0 10.1016/S0002-8703(03)00415-0 . DOI: 10.1016/S0002-8703(03)00415-0 http://doi.org/10.1016/S0002-8703(03)00415-0 https://www.ncbi.nlm.nih.gov/pubmed/14597947 https://www.ncbi.nlm.nih.gov/pubmed/14597947

D’Souza A , Hussain M , Howarth FC , et al . Pathogenesis and pathophysiology of accelerated atherosclerosis in the diabetic heart . Mol Cell Biochem 2009 ; 331 ( 1-2 ): 89 - 116 . doi: 10.1007/s11010-009-0148-8 10.1007/s11010-009-0148-8 . DOI: 10.1007/s11010-009-0148-8 http://doi.org/10.1007/s11010-009-0148-8 http://www.springerlink.com/content/j1j381023187u127/ http://www.springerlink.com/content/j1j381023187u127/

Gartner V , Eigentler TK . Pathogenesis of diabetic macro- and microangiopathy . Clin Nephrol 2008 ; 70 ( 1 ): 1 - 9 . doi: 10.5414/cnp70001 10.5414/cnp70001 . DOI: 10.5414/cnp70001 http://doi.org/10.5414/cnp70001 https://www.ncbi.nlm.nih.gov/pubmed/18793542 https://www.ncbi.nlm.nih.gov/pubmed/18793542

Vinik A , Flemmer M . Diabetes and macrovascular disease . J Diabetes Complications 2002 ; 16 ( 3 ): 235 - 45 . doi: 10.1016/s1056-8727(01)00212-4 10.1016/s1056-8727(01)00212-4 . DOI: 10.1016/s1056-8727(01)00212-4 http://doi.org/10.1016/s1056-8727(01)00212-4 https://www.ncbi.nlm.nih.gov/pubmed/12015194 https://www.ncbi.nlm.nih.gov/pubmed/12015194

Natali A , Vichi S , Landi P , et al . Coronary atherosclerosis in type II diabetes: angiographic findings and clinical outcome . Diabetologia 2000 ; 43 ( 5 ): 632 - 41 . doi: 10.1007/s001250051352 10.1007/s001250051352 . https://www.ncbi.nlm.nih.gov/pubmed/10855538 https://www.ncbi.nlm.nih.gov/pubmed/10855538

Dalen JE , Alpert JS , Goldberg RJ , et al . The epidemic of the 20(th) century: coronary heart disease . Am J Med 2014 ; 127 ( 9 ): 807 - 12 . doi: 10.1016/j.amjmed.2014.04.015 10.1016/j.amjmed.2014.04.015 . DOI: 10.1016/j.amjmed.2014.04.015 http://doi.org/10.1016/j.amjmed.2014.04.015 http://dx.doi.org/10.1016/j.amjmed.2014.04.015 http://dx.doi.org/10.1016/j.amjmed.2014.04.015

Danchin N , Marzilli M , Parkhomenko A , et al . Efficacy comparison of trimetazidine with therapeutic alternatives in stable angina pectoris: a network meta-analysis . Cardiology 2011 ; 120 ( 2 ): 59 - 72 . doi: 10.1159/000332369 10.1159/000332369 . DOI: 10.1159/000332369 http://doi.org/10.1159/000332369 https://www.ncbi.nlm.nih.gov/pubmed/22122948 https://www.ncbi.nlm.nih.gov/pubmed/22122948

Jandeleit-Dahm K , Watson A , Soro-Paavonen A . The AGE/RAGE axis in diabetes-accelerated atherosclerosis . Clin Expe Pharmacol Physiol 2008 ; 35 ( 3 ): 329 - 34 . doi: 10.1111/j.1440-1681.2007.04875.x 10.1111/j.1440-1681.2007.04875.x .

Wautier JL , Schmidt AM . Protein glycation: a firm link to endothelial cell dysfunction . Circ Res 2004 ; 95 ( 3 ): 233 - 8 . doi: 10.1161/01.RES.0000137876.28454.64 10.1161/01.RES.0000137876.28454.64 . https://www.ncbi.nlm.nih.gov/pubmed/15297385 https://www.ncbi.nlm.nih.gov/pubmed/15297385

Xanthis A , Hatzitolios A , Koliakos G , et al . Advanced glycosylation end products and nutrition―a possible relation with diabetic atherosclerosis and how to prevent it . J Food Sci 2007 ; 72 ( 8 ): R125 - 9 . doi: 10.1111/j.1750-3841.2007.00508.x 10.1111/j.1750-3841.2007.00508.x . DOI: 10.1111/j.1750-3841.2007.00508.x http://doi.org/10.1111/j.1750-3841.2007.00508.x https://www.ncbi.nlm.nih.gov/pubmed/17995617 https://www.ncbi.nlm.nih.gov/pubmed/17995617

Katakami N , Kaneto H , Matsuoka TA , et al . Accumulation of oxidative stress-related gene polymorphisms and the risk of coronary heart disease events in patients with type 2 diabetes--an 8-year prospective study . Atherosclerosis 2014 ; 235 ( 2 ): 408 - 14 . doi: 10.1016/j.atherosclerosis.2014.05.936 10.1016/j.atherosclerosis.2014.05.936 . DOI: 10.1016/j.atherosclerosis.2014.05.936 http://doi.org/10.1016/j.atherosclerosis.2014.05.936 https://www.ncbi.nlm.nih.gov/pubmed/24933031 https://www.ncbi.nlm.nih.gov/pubmed/24933031

Chen YR , Zweier JL . Cardiac mitochondria and reactive oxygen species generation . Circ Res 2014 ; 114 ( 3 ): 524 - 37 . doi: 10.1161/CIRCRESAHA.114.300559 10.1161/CIRCRESAHA.114.300559 . https://www.ncbi.nlm.nih.gov/pubmed/24481843 https://www.ncbi.nlm.nih.gov/pubmed/24481843

Blake R , Trounce IA . Mitochondrial dysfunction and complications associated with diabetes . Biochim Biophys Acta 2014 ; 1840 ( 4 ): 1404 - 12 . doi: 10.1016/j.bbagen.2013.11.007 10.1016/j.bbagen.2013.11.007 . DOI: 10.1016/j.bbagen.2013.11.007 http://doi.org/10.1016/j.bbagen.2013.11.007 https://www.ncbi.nlm.nih.gov/pubmed/24246956 https://www.ncbi.nlm.nih.gov/pubmed/24246956

van den Oever IA , Raterman HG , Nurmohamed MT , et al . Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus . Mediators Inflamm 2010 ; 2010 : 792393 . doi: 10.1155/2010/792393 10.1155/2010/792393 . DOI: 10.1155/2010/792393 http://doi.org/10.1155/2010/792393 https://www.ncbi.nlm.nih.gov/pubmed/20634940 https://www.ncbi.nlm.nih.gov/pubmed/20634940

Maack C , Dabew ER , Hohl M , et al . Endogenous activation of mitochondrial KATP channels protects human failing myocardium from hydroxyl radical-induced stunning . Circ Res 2009 ; 105 ( 8 ): 811 - 7 . doi: 10.1161/CIRCRESAHA.109.206359 10.1161/CIRCRESAHA.109.206359 . https://www.ncbi.nlm.nih.gov/pubmed/19729596 https://www.ncbi.nlm.nih.gov/pubmed/19729596

Giordano FJ . Oxygen, oxidative stress, hypoxia, and heart failure . J Clin Investig 2005 ; 115 ( 3 ): 500 - 8 . doi: 10.1172/JCI24408 10.1172/JCI24408 . DOI: 10.1172/JCI24408 http://doi.org/10.1172/JCI24408 https://www.ncbi.nlm.nih.gov/pubmed/15765131 https://www.ncbi.nlm.nih.gov/pubmed/15765131

Akar FG , Aon MA , Tomaselli GF , et al . The mitochondrial origin of postischemic arrhythmias . J Clin Investig 2005 ; 115 ( 12 ): 3527 - 35 . doi: 10.1172/JCI25371 10.1172/JCI25371 . https://www.ncbi.nlm.nih.gov/pubmed/16284648 https://www.ncbi.nlm.nih.gov/pubmed/16284648

Kurokawa S , Niwano S , Niwano H , et al . Progression of ventricular remodeling and arrhythmia in the primary hyperoxidative state of glutathione-depleted rats . Circulation J 2011 ; 75 ( 6 ): 1386 - 93 . doi: 10.1253/circj.cj-10-1089 10.1253/circj.cj-10-1089 . DOI: 10.1253/circj.CJ-10-1089 http://doi.org/10.1253/circj.CJ-10-1089 http://joi.jlc.jst.go.jp/JST.JSTAGE/circj/CJ-10-1089?from=CrossRef http://joi.jlc.jst.go.jp/JST.JSTAGE/circj/CJ-10-1089?from=CrossRef

Monteiro P , Duarte AI , Goncalves LM , et al . Protective effect of trimetazidine on myocardial mitochondrial function in an ex-vivo model of global myocardial ischemia . Eur J Pharmacol 2004 ; 503 ( 1-3 ): 123 - 8 . doi: 10.1016/j.ejphar.2004.09.003 10.1016/j.ejphar.2004.09.003 . https://www.ncbi.nlm.nih.gov/pubmed/15496306 https://www.ncbi.nlm.nih.gov/pubmed/15496306

Wu Q , Qi B , Liu Y , et al . Mechanisms underlying protective effects of trimetazidine on endothelial progenitor cells biological functions against H2O2-induced injury: involvement of antioxidation and Akt/eNOS signaling pathways . Eur J Pharmacol 2013 ; 707 ( 1-3 ): 87 - 94 . doi: 10.1016/j.ejphar.2013.03.027 10.1016/j.ejphar.2013.03.027 . DOI: 10.1016/j.ejphar.2013.03.027 http://doi.org/10.1016/j.ejphar.2013.03.027 https://www.ncbi.nlm.nih.gov/pubmed/23528356 https://www.ncbi.nlm.nih.gov/pubmed/23528356

Dehina L , Vaillant F , Tabib A , et al . Trimetazidine demonstrated cardioprotective effects through mitochondrial pathway in a model of acute coronary ischemia . Naunyn Schmiedebergs Arch Pharmacol 2013 ; 386 ( 3 ): 205 - 15 . doi: 10.1007/s00210-012-0826-z 10.1007/s00210-012-0826-z . DOI: 10.1007/s00210-012-0826-z http://doi.org/10.1007/s00210-012-0826-z https://www.ncbi.nlm.nih.gov/pubmed/23263451 https://www.ncbi.nlm.nih.gov/pubmed/23263451

Senturk T , Cavun S , Avci B , et al . Effective inhibition of cardiomyocyte apoptosis through the combination of trimetazidine and N-acetylcysteine in a rat model of myocardial ischemia and reperfusion injury . Atherosclerosis 2014 ; 237 ( 2 ): 760 - 6 . doi: 10.1016/j 10.1016/j . DOI: 10.1016/j.atherosclerosis.2014.10.091 http://doi.org/10.1016/j.atherosclerosis.2014.10.091 http://dx.doi.org/10.1016/j.atherosclerosis.2014.10.091 http://dx.doi.org/10.1016/j.atherosclerosis.2014.10.091

atherosclerosis . 2014 . 10 . 091 .

Zhou X , Li C , Xu W , et al . Trimetazidine protects against smoking-induced left ventricular remodeling via attenuating oxidative stress, apoptosis, and inflammation . PloS One 2012 ; 7 ( 7 ): e40424 . doi: 10.1371/journal.pone.0040424 10.1371/journal.pone.0040424 . https://www.ncbi.nlm.nih.gov/pubmed/22792312 https://www.ncbi.nlm.nih.gov/pubmed/22792312

Zhang L , Ding WY , Wang ZH , et al . Early administration of trimetazidine attenuates diabetic cardiomyopathy in rats by alleviating fibrosis, reducing apoptosis and enhancing autophagy . J Transl Med 2016 ; 14 ( 1 ): 109 . doi: 10.1186/s12967-016-0849-1 10.1186/s12967-016-0849-1 . DOI: 10.1186/s12967-016-0849-1 http://doi.org/10.1186/s12967-016-0849-1 https://www.ncbi.nlm.nih.gov/pubmed/27121077 https://www.ncbi.nlm.nih.gov/pubmed/27121077

Vitale C , Marazzi G , Pelliccia F , et al . Trimetazidine improves exercise performance in patients with peripheral arterial disease . Pharmacol Res 2011 ; 63 ( 4 ): 278 - 83 . doi: 10.1016/j.phrs.2011.01.003 10.1016/j.phrs.2011.01.003 . DOI: 10.1016/j.phrs.2011.01.003 http://doi.org/10.1016/j.phrs.2011.01.003 https://www.ncbi.nlm.nih.gov/pubmed/21220024 https://www.ncbi.nlm.nih.gov/pubmed/21220024

Tuunanen H , Engblom E , Naum A , et al . Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy . Circulation 2008 ; 118 ( 12 ): 1250 - 8 . doi: 10.1161/CIRCULATIONAHA.108.778019 10.1161/CIRCULATIONAHA.108.778019 . DOI: 10.1161/CIRCULATIONAHA.108.778019 http://doi.org/10.1161/CIRCULATIONAHA.108.778019 https://www.ncbi.nlm.nih.gov/pubmed/18765391 https://www.ncbi.nlm.nih.gov/pubmed/18765391

Fazakerley DJ , Holman GD , Marley A , et al . Kinetic evidence for unique regulation of GLUT4 trafficking by insulin and AMP-activated protein kinase activators in L6 myotubes . J Bio Chem 2010 ; 285 ( 3 ): 1653 - 60 . doi: 10.1074/jbc.M109.051185 10.1074/jbc.M109.051185 . DOI: 10.1074/jbc.M109.051185 http://doi.org/10.1074/jbc.M109.051185 http://www.jbc.org/lookup/doi/10.1074/jbc.M109.051185 http://www.jbc.org/lookup/doi/10.1074/jbc.M109.051185

Orekhov AN , Bobryshev YV , Sobenin IA , et al . Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease . Int J Mol Sci 2014 ; 15 ( 7 ): 12807 - 41 . doi: 10.3390/ijms150712807 10.3390/ijms150712807 . DOI: 10.3390/ijms150712807 http://doi.org/10.3390/ijms150712807 https://www.ncbi.nlm.nih.gov/pubmed/25050779 https://www.ncbi.nlm.nih.gov/pubmed/25050779

Yang H , Mohamed AS , Zhou SH . Oxidized low density lipoprotein, stem cells, and atherosclerosis . Lipids Health Dis 2012 ; 11 : 85 . doi: 10.1186/1476-511X-11-85 10.1186/1476-511X-11-85 . https://www.ncbi.nlm.nih.gov/pubmed/22747902 https://www.ncbi.nlm.nih.gov/pubmed/22747902

Peng S , Zhao M , Wan J , et al . The efficacy of trimetazidine on stable angina pectoris: a meta-analysis of randomized clinical trials . Int J Cardiol 2014 ; 177 ( 3 ): 780 - 5 . doi: 10.1016/j.ijcard.2014.10.149 10.1016/j.ijcard.2014.10.149 . DOI: 10.1016/j.ijcard.2014.10.149 http://doi.org/10.1016/j.ijcard.2014.10.149 https://www.ncbi.nlm.nih.gov/pubmed/25466565 https://www.ncbi.nlm.nih.gov/pubmed/25466565

Marzilli M , Klein WW . Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis of randomized, double-blind, controlled trials . Coron Artery Dis 2003 ; 14 ( 2 ): 171 - 9 . doi: 10.1097/00019501-200304000-00010 10.1097/00019501-200304000-00010 . DOI: 10.1097/00019501-200304000-00010 http://doi.org/10.1097/00019501-200304000-00010 https://www.ncbi.nlm.nih.gov/pubmed/12655281 https://www.ncbi.nlm.nih.gov/pubmed/12655281

Zhao Y , Peng L , Luo Y , et al . Trimetazidine improves exercise tolerance in patients with ischemic heart disease: a meta-analysis . Herz 2016 ; 41 ( 6 ): 514 - 22 . doi: 10.1007/s00059-015-4392-2 10.1007/s00059-015-4392-2 . DOI: 10.1007/s00059-015-4392-2 http://doi.org/10.1007/s00059-015-4392-2 https://www.ncbi.nlm.nih.gov/pubmed/26668006 https://www.ncbi.nlm.nih.gov/pubmed/26668006

Borlaug BA , Melenovsky V , Russell SD , et al . Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction . Circulation 2006 ; 114 ( 20 ): 2138 - 47 . doi: 10.1161/CIRCULATIONAHA.106.632745 10.1161/CIRCULATIONAHA.106.632745 . https://www.ncbi.nlm.nih.gov/pubmed/17088459 https://www.ncbi.nlm.nih.gov/pubmed/17088459

Wei Y , Chen K , Whaley-Connell AT , et al . Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species . Am J Physiol 2008 ; 294 ( 3 ): R673 - 80 . doi: 10.1152/ajpregu.00561.2007 10.1152/ajpregu.00561.2007 .

Zeyda M , Stulnig TM . Obesity, inflammation, and insulin resistance―a mini-review . Gerontology 2009 ; 55 ( 4 ): 379 - 86 . doi: 10.1159/000212758 10.1159/000212758 . DOI: 10.1159/000212758 http://doi.org/10.1159/000212758 https://www.ncbi.nlm.nih.gov/pubmed/19365105 https://www.ncbi.nlm.nih.gov/pubmed/19365105

Roberts AC , Porter KE . Cellular and molecular mechanisms of endothelial dysfunction in diabetes . Diab Vasc Dis Res 2013 ; 10 ( 6 ): 472 - 82 . doi: 10.1177/1479164113500680 10.1177/1479164113500680 . DOI: 10.1177/1479164113500680 http://doi.org/10.1177/1479164113500680 https://www.ncbi.nlm.nih.gov/pubmed/24002671 https://www.ncbi.nlm.nih.gov/pubmed/24002671

浏览量

730

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

关联资源

Methylenetetrahydrofolate Reductase Gene Polymorphism C677T is Associated with Increased Risk of Coronary Heart Disease in Chinese Type 2 Diabetic Patients

Five-year Clinical Outcomes of CAD Patients Complicated with Diabetes after StentBoost-optimized Percutaneous Coronary Intervention

Can Fundus Fluorescein Angiography be Performed for Diabetic Patients on Oral Metformin?^△